search
Back to results

Back Pain Prevention in Multiple Myeloma Using an External Spinal Brace (MAPP)

Primary Purpose

Multiple Myeloma

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
thoracolumbosacral orthosis or cervicothoracolumbar orthosis
Standard care
Sponsored by
University Hospitals of North Midlands NHS Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Multiple Myeloma

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adults with MM
  • Myeloma infiltration in the spine confirmed by radiological evidence
  • MM-related back pain
  • Can attend for the whole follow up period

Exclusion Criteria:

  • Presenting with cord compression and neurological deficit requiring urgent decompression and intervention
  • Chronic pain syndrome
  • Language barrier that cannot be overcome using translation services
  • Unwilling or unable to give informed consent
  • Painful VCFs at the lumbosacral junction, L4 to Sacrum, where application of brace is not possible.

Not suitable for treatment with a brace e.g. pregnancy

Sites / Locations

  • University Hospitals of North Midlands NHS Trust

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Other

Arm Label

Standard care + brace

Standard care

Arm Description

Spinal brace (thoracolumbosacral orthosis or cervico-thoraco-lumbar orthosis) to be fitted to the participant in addition to receiving standard of care treatment which can include radiotherapy, chemotherapy or surgery including vertebral augmentation and also medication including bisphosphonates

Participant will receive standard of care treatment which can include radiotherapy, chemotherapy or surgery including vertebral augmentation and also medication including bisphosphonates

Outcomes

Primary Outcome Measures

Time from diagnosis to brace fitting for patients randomised to the intervention group
Number of patients in the intervention arm who request additional support from the orthotic team and time they had to wait for support.
The number of orthotists in each hospital
Are appropriate braces fitted
The locations and levels of VCFs and back pain in patients and the type of brace fitted will be recorded to determine whether appropriate braces are fitted.
Number of appointments issued by orthotists
Frequency of appointments issued by orthotists

Secondary Outcome Measures

The number of new MM cases at each centre
The number of eligible patients who give consent to enter the study
The number of patients that drop-out during follow-up and their reasons
The number of missing cases for a subsequent RCTs co-primary outcomes of pain and disability
Pain measured by VAS
Descriptive statistics and qualitative analysis of the 3-month follow up patient questionnaire
The questionnaire consists principally of ordinal rating scales, which will be analysed descriptively in terms of frequencies, medians and interquartile ranges. Qualitative data from the supplementary open-ended questions will be analysed by means of framework analysis.
Qualitative assessment of semi structured interviews in a sub-set of participants, EQ-5D-5L
The number of patients who receive non-study-related interventions during the 3 month follow-up period
Disability measured by ODI
Number of patients eligible for the study during 1 recruitment year.

Full Information

First Posted
June 29, 2016
Last Updated
July 1, 2019
Sponsor
University Hospitals of North Midlands NHS Trust
search

1. Study Identification

Unique Protocol Identification Number
NCT02898064
Brief Title
Back Pain Prevention in Multiple Myeloma Using an External Spinal Brace
Acronym
MAPP
Official Title
Back Pain Prevention in Multiple Myeloma Using an External Spinal Brace - a Feasibility Study
Study Type
Interventional

2. Study Status

Record Verification Date
July 2019
Overall Recruitment Status
Completed
Study Start Date
December 19, 2016 (Actual)
Primary Completion Date
May 31, 2018 (Actual)
Study Completion Date
May 31, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospitals of North Midlands NHS Trust

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Consenting patients with multiple myeloma (MM) will be randomly allocated to receive either standard medical treatment (chemotherapy, radiotherapy, pain-killing medication) alone or standard medical treatment plus a brace. Patients will be regularly evaluated in research clinics; the results data will inform the design of a full trial. Information will be collected to inform a list of requirements a centre needs to have in place to run an RCT of these interventions.
Detailed Description
Multiple myeloma (MM) is a neoplasia of plasma cells mostly within the bone marrow, commonly leading to multiple vertebral collapses. This causes spinal deformity, leading to incapacitating back pain and reduced quality of life. In spite of advances in medical therapy, some patients are left with disabling back pain, sometimes requiring surgical intervention. University Hospitals of North Midlands NHS Trust have observed on an audit of our own practice that application of an external spinal brace as early in the disease process as is possible appears to maintain the overall alignment of the spine, thus minimising risk of spinal deformity and consequent back pain. The ultimate aim is to undertake an RCT to determine whether the use of an external spinal brace can reduce back pain and spine-related disability in patients suffering from back pain due to multiple myeloma, in comparison to conventional management without a brace. However, prior to this, a feasibility study is required. The feasibility study is needed to see if the trial processes (providing patient information, consent process, conducting the baseline investigations and outcome measures) can be accommodated without causing too much delay to the application of the brace. Suitable patients will be consented by the research team and randomised to receive a brace or no brace in addition to their routine Myeloma treatment. After baseline data collection and questionnaires, the participant would be followed up for data collection at 6 weeks and 3 months.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Multiple Myeloma

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
2 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Standard care + brace
Arm Type
Other
Arm Description
Spinal brace (thoracolumbosacral orthosis or cervico-thoraco-lumbar orthosis) to be fitted to the participant in addition to receiving standard of care treatment which can include radiotherapy, chemotherapy or surgery including vertebral augmentation and also medication including bisphosphonates
Arm Title
Standard care
Arm Type
Other
Arm Description
Participant will receive standard of care treatment which can include radiotherapy, chemotherapy or surgery including vertebral augmentation and also medication including bisphosphonates
Intervention Type
Device
Intervention Name(s)
thoracolumbosacral orthosis or cervicothoracolumbar orthosis
Other Intervention Name(s)
spinal brace
Intervention Description
An "off the shelf spinal brace" which will be applied to the patients trunk. They will have straps and harnesses which the patient can fasten and remove if needed. The brace will need to be worn by the intervention group all the time for 3 months except when lying in bed. In the presence of lower thoracic (T8 downwards), thoraco-lumbar and lumbar (L1- L3) fractures, a thoracolumbosacral orthosis will be applied. For upper thoracic fractures (T1-T7) a cervico-thoracic or cervico-thoraco-lumbar orthosis will be used.
Intervention Type
Other
Intervention Name(s)
Standard care
Intervention Description
Standard surgery, radiotherapy, chemotherapy, drug therapy as applicable and decided by the participants consultant as part of standard care
Primary Outcome Measure Information:
Title
Time from diagnosis to brace fitting for patients randomised to the intervention group
Time Frame
Assessed at 3 months
Title
Number of patients in the intervention arm who request additional support from the orthotic team and time they had to wait for support.
Time Frame
assessed at the end of study at 21 months
Title
The number of orthotists in each hospital
Time Frame
21 months
Title
Are appropriate braces fitted
Description
The locations and levels of VCFs and back pain in patients and the type of brace fitted will be recorded to determine whether appropriate braces are fitted.
Time Frame
6 weeks
Title
Number of appointments issued by orthotists
Time Frame
21 months
Title
Frequency of appointments issued by orthotists
Time Frame
21 months
Secondary Outcome Measure Information:
Title
The number of new MM cases at each centre
Time Frame
1 year
Title
The number of eligible patients who give consent to enter the study
Time Frame
21 months
Title
The number of patients that drop-out during follow-up and their reasons
Time Frame
21 months
Title
The number of missing cases for a subsequent RCTs co-primary outcomes of pain and disability
Time Frame
21 months
Title
Pain measured by VAS
Time Frame
6 weeks and 3 months
Title
Descriptive statistics and qualitative analysis of the 3-month follow up patient questionnaire
Description
The questionnaire consists principally of ordinal rating scales, which will be analysed descriptively in terms of frequencies, medians and interquartile ranges. Qualitative data from the supplementary open-ended questions will be analysed by means of framework analysis.
Time Frame
3 months
Title
Qualitative assessment of semi structured interviews in a sub-set of participants, EQ-5D-5L
Time Frame
21 months
Title
The number of patients who receive non-study-related interventions during the 3 month follow-up period
Time Frame
3 months
Title
Disability measured by ODI
Time Frame
6 weeks and 3 months
Title
Number of patients eligible for the study during 1 recruitment year.
Time Frame
1 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adults with MM Myeloma infiltration in the spine confirmed by radiological evidence MM-related back pain Can attend for the whole follow up period Exclusion Criteria: Presenting with cord compression and neurological deficit requiring urgent decompression and intervention Chronic pain syndrome Language barrier that cannot be overcome using translation services Unwilling or unable to give informed consent Painful VCFs at the lumbosacral junction, L4 to Sacrum, where application of brace is not possible. Not suitable for treatment with a brace e.g. pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sandeep Konduru
Organizational Affiliation
University Hospitals of North Midlands NHS Trust
Official's Role
Study Director
Facility Information:
Facility Name
University Hospitals of North Midlands NHS Trust
City
Stoke-on-Trent
State/Province
Staffordshire
ZIP/Postal Code
ST4 6QG
Country
United Kingdom

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Only anonymised patient data would be published

Learn more about this trial

Back Pain Prevention in Multiple Myeloma Using an External Spinal Brace

We'll reach out to this number within 24 hrs